Targeting Mcl-1 enhances DNA replication stress sensitivity to cancer therapy
Guo Chen, … , Paul W. Doetsch, Xingming Deng
Guo Chen, … , Paul W. Doetsch, Xingming Deng
Published December 11, 2017
Citation Information: J Clin Invest. 2018;128(1):500-516. https://doi.org/10.1172/JCI92742.
View: Text | PDF
Research Article Cell biology Article has an altmetric score of 27

Targeting Mcl-1 enhances DNA replication stress sensitivity to cancer therapy

Abstract

DNA double-strand breaks (DSBs) are mainly repaired either by homologous recombination (HR) or by nonhomologous end-joining (NHEJ) pathways. Here, we showed that myeloid cell leukemia sequence 1 (Mcl-1) acts as a functional switch in selecting between HR and NHEJ pathways. Mcl-1 was cell cycle–regulated during HR, with its expression peaking in S/G2 phase. While endogenous Mcl-1 depletion reduced HR and enhanced NHEJ, Mcl-1 overexpression resulted in a net increase in HR over NHEJ. Mcl-1 directly interacted with the dimeric Ku protein complex via its Bcl-2 homology 1 and 3 (BH1 and BH3) domains, which are required for Mcl-1 to inhibit Ku-mediated NHEJ. Mcl-1 also promoted DNA resection mediated by the Mre11 complex and HR-dependent DSB repair. Using the Mcl-1 BH1 domain as a docking site, we identified a small molecule, MI-223, that directly bound to BH1 and blocked Mcl-1–stimulated HR DNA repair, leading to sensitization of cancer cells to hydroxyurea- or olaparib-induced DNA replication stress. Combined treatment with MI-223 and hydroxyurea or olaparib exhibited a strong synergy against lung cancer in vivo. This mechanism-driven combination of agents provides a highly attractive therapeutic strategy to improve lung cancer outcomes.

Authors

Guo Chen, Andrew T. Magis, Ke Xu, Dongkyoo Park, David S. Yu, Taofeek K. Owonikoko, Gabriel L. Sica, Sarah W. Satola, Suresh S. Ramalingam, Walter J. Curran, Paul W. Doetsch, Xingming Deng

×

Figure 3

Mcl-1 is essential for DSB repair via HR in S/G2 cells.

Options: View larger image (or click on image) Download as PowerPoint
Mcl-1 is essential for DSB repair via HR in S/G2 cells. (A) Endogenous M...
(A) Endogenous Mcl-1 was knocked out from H1299 using CRISPR/Cas9 system. (B) H1299 parental and H1299 Mcl1–/– cells were treated with IR (0.5 Gy), followed by costaining with cyclin A and γ-H2AX antibodies immediately or after 7 hours. Cyclin A is a well-known S/G2 marker; therefore, cyclin A–positive cells are considered as S/G2-phase cells. Scale bar: 25 μm. The γ-H2AX foci per cell were determined by counting of at least 100 cells from each sample. Data represent the mean ± SD, n = 3 per group. ***P < 0.001, by 2-tailed t test. (C) H1299 parental and H1299 Mcl1–/– cells were treated with IR (0.5 Gy), followed by costaining with cyclin A and Rad51 antibodies. Scale bar: 25 μm. The Rad51 foci per cell were determined by counting of at least 100 cells from each sample. Data represent the mean ± SD, n = 3 per group. ***P < 0.001, by 2-tailed t test.